Skip to content
Screener

Harrow HROW Net Change in Cash

Net Change in Cash at other companies

AbbVie logo
AbbVieABBV
$4.16B+1,293%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-$6.28M-353%
Bausch + Lomb logo
Bausch + LombBLCO
-$118M-16.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$70.36M-65.9%
Opko Health logo
Opko HealthOPK
-$41.14M+75.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$13M+70.5%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line item2026 / For the Three Months Ended March 31,2025 / For the Three Months Ended March 31,
Payment of debt issuance costs(113,000)-
Proceeds from exercise of stock options25,00023,000
NET CASH PROVIDED BY FINANCING ACTIVITIES48,912,00023,000
NET CHANGE IN CASH AND CASH EQUIVALENTS21,717,00019,479,000
CASH AND CASH EQUIVALENTS, beginning of period72,927,00047,247,000
CASH, CASH EQUIVALENTS, end of period$94,644,000$66,726,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes-$38,000

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's net change in cash?
Harrow (HROW) reported net change in cash of $21.72M in Q1 2026.
How has Harrow's net change in cash changed year-over-year?
Harrow's net change in cash increased by 11.5% year-over-year, from $19.48M to $21.72M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Harrow's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude